UNSPSC 51181622: Tiratricol

This classification denotes a thyroid agent with the molecular formula C14H9I3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 29OQ9EU4R1, chemically known as 3,3,5-triiodothyroacetic acid but generally known as tiratricol, which bears US NIH Compound Identifier 5803. European Medicines Agency schedules Tiratricol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11116MIG.

UNSPSC 51181622 Tiratricol is a Commodity code for a synthetic thyroid hormone analog used in pharmaceutical and medical applications. State and local governments procure tiratricol primarily through health departments, correctional facilities, public hospitals, and clinical research institutions as part of formulary management, inmate medical services, and therapeutic protocols. The product appears in solicitations for bulk pharmaceutical supplies, hospital pharmacy inventory replenishment, and medical research support where thyroid hormone replacement or metabolic regulation is indicated. Issuing bodies span state health agencies, county-operated detention and correction systems, municipal and regional hospital networks, and university-affiliated medical centers.

The source provided contains no records of recent state and local contract opportunities under this code, so the geographic distribution and timing of current procurement activity cannot be determined. Without posted RFP, RFQ, IFB, or ITB notices, no representative solicitations are available to profile issuing-body frequency, response dates, or active buying jurisdictions. Firms evaluating this code should monitor health department and corrections procurement channels in states with large public-health or correctional infrastructure, though the sparse visibility suggests tiratricol may be procured through standing pharmaceutical cooperative agreements or routine formulary orders rather than open competitive solicitation.